AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Evaluating Cochlear Limited's Stock Valuation A Comprehensive Analysis
February 09, 2025 03:31 PM AEDT| By Team Kalkine MediaEvaluating Cochlear Limited's Stock Valuation A Comprehensive Analysis
Does Oneview Healthcare's Ownership Makeup Reflect a Broad Investor Base?
February 08, 2025 03:30 PM AEDT| By Team Kalkine MediaHighlights,A majority of the shares are possessed by individual investors.,A select group of major shareholders manages a considerable portion of the distribution.,Recent share acquisitions by company management have been recorded.,Oneview Healthcare...
Neuren Pharmaceuticals (ASX:NEU) Advances FDA Discussions for Phase 3 Clinical Trial
February 07, 2025 11:22 AM AEDT| By Team Kalkine MediaHighlights,Neuren,Pharmaceuticals (,ASX:NEU,) has secured a Type C meeting with the FDA to discuss efficacy endpoints for its Phase 3 trial of NNZ-2591.,NNZ-2591 showed promising results in treating neurodevelopmental disorders, including Phelan-McDe...
ASX Healthcare Stocks: Navigating Global Tariff Pressures and Market Volatility
February 07, 2025 11:00 AM AEDT| By Team Kalkine MediaASX Healthcare Stocks: Navigating Global Tariff Pressures and Market Volatility
Orthocell's Remarkable Performance Navigating Rapid Revenue Growth and Dynamic Stock Gains
February 07, 2025 09:32 AM AEDT| By Team Kalkine MediaOrthocell's Remarkable Performance Navigating Rapid Revenue Growth and Dynamic Stock Gains
Compumedics Limited (ASX:CMP) Unraveling Valuation Discrepancies Amid Robust Revenue Growth
February 07, 2025 09:31 AM AEDT| By Team Kalkine MediaCompumedics Limited (ASX:CMP) Unraveling Valuation Discrepancies Amid Robust Revenue Growth
Is SGH Limited's Valuation Justified by Its Growth Outlook?
February 06, 2025 05:34 PM AEDT| By Team Kalkine MediaHighlights,SGH Limited operates within a dynamic healthcare and property services sector.,The company trades with a price-to-earnings ratio considerably above the market average.,Market expectations point to higher future growth compared to other Aus...
A Look at Neuren Pharmaceuticals Limited (ASX:NEU) and Its Current Valuation
February 06, 2025 03:19 PM AEDT| By Team Kalkine MediaHighlights:,Neuren Pharmaceuticals,(ASX:NEU),operates within the biotechnology sector, focusing on treatments for neurological disorders.,The company's current valuation is based on a financial assessment of expected future cash flows.,A Discounted C...
AdAlta (ASX:1AD) Unveils 'East to West' Strategy, Shifting Focus from AD-214
February 06, 2025 11:38 AM AEDT| By Team Kalkine MediaHighlights:,New Strategic Direction:,AdAlta,(ASX:1AD) has introduced its 'East to West' strategy, aiming to source cellular immunotherapy candidates from Southeast Asia, refine them through,early-stage,testing in Australia, and license them to Wester...
Health Check: When Record Results Fall Short of Investor Expectations
February 06, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,PolyNovo Reports Market Fluctuations:,Despite strong financial results, PolyNovo (ASX:PNV) experienced stock price movements due to revenue and profit figures falling slightly below market expectations.,Cyclopharm Expands in the US:,Cyclo...
Can This New Patent Propel NUZ-001 Forward?
February 05, 2025 06:11 PM AEDT| By Team Kalkine MediaHighlights,Neurizon secures a U.S. patent for NUZ-001’s novel method of use.,The intellectual property framework receives a robust enhancement.,Licensing and commercialization frameworks gain strategic reinforcement.,Neurizon (ASX:NUZ) recently achie...
Can ASX:CYP Reshape Stem Cell Manufacturing?
February 05, 2025 06:10 PM AEDT| By Team Kalkine MediaHighlights,Cynata herapeutics (ASX:CYP) develops iPSC-derived MSCs comparable to traditional bone marrow sources in regenerative function.,A peer-reviewed study conducted with a renowned research center examines the attributes and consistency of vari...
Little Green Pharma Acquires Health House in Strategic Expansion, Shares Rise 4%
February 05, 2025 03:22 PM AEDT| By Team Kalkine MediaHighlights,Strategic Acquisition:,Little Green Pharma acquires Health House to enhance vertical integration.,Low-Cost Deal:,The acquisition cost is,$375,000,, a fraction of the,$10.9 million,price tag listed in 2024.,Market Reaction:,LGP shares rose,...
Has Neurizon Therapeutics Secured a Pivotal US Patent for NUZ-001?
February 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,US patent secures protection for NUZ-001 in neurodegenerative conditions and cancer.,Patent follows FDA Orphan Drug Designation, reinforcing US market strategy.,Protection for NUZ-001 extends in the United States until the late 2030s,Neuri...
Why Has MedAdvisor (ASX:MDR) Seen a Significant Decline in Share Price?
February 04, 2025 01:30 PM AEDT| By Team Kalkine MediaHighlights:,MedAdvisor's share price has experienced a noticeable decline recently.,The company's price-to-sales ratio is significantly lower than the healthcare industry average.,Revenue growth projections for MedAdvisor fall behind the industry’s e...
Wellnex Life (ASX:WNX) Secures TGA Approval for Liquid Paracetamol & Caffeine Soft Gel
February 04, 2025 01:14 PM AEDT| By Team Kalkine MediaHighlights:,TGA grants Market Authorisation (MA) for the innovative liquid paracetamol and caffeine combination.,Wellnex,Life (,ASX:WNX,) experiences a 6% share price increase amid low trading volume.,Expansion of the product portfolio strengthens th...
Breakthrough Preclinical Study: ARG-007 Demonstrates Neuroprotective Action in Traumatic Brain Injury Models (ASX:AGN)
February 04, 2025 01:12 PM AEDT| By Team Kalkine MediaHighlights,Neuroinflammation Reduction:,Early-stage evidence,indicates,that ARG-007 significantly reduces neuroinflammation in a rat model of traumatic brain injury (TBI).,Biomarker Normalization:,Biomarker levels associated with TBI in treated rats...
Nufarm Shares Surge on Strong Growth Outlook for Omega-3 Products
February 04, 2025 11:27 AM AEDT| By Team Kalkine MediaHighlights,Nufarm shares rise 4.8% to AU$3.73, their highest level since December 13.,FY25 revenue forecast for plant-based omega-3 products doubles to AU$100 million, up from AU$50 million in FY24.,Shares spiked as much as 7.1% intraday, marking the...
Noxopharm's Flagship Lupus Therapy Clears Early Safety Hurdles in Lab Tests
February 04, 2025 11:16 AM AEDT| By Team Kalkine MediaHighlights,SOF-SKN Advances:,The experimental topical drug, SOF-SKN, has successfully passed its first round of in vitro safety tests.,Robust Safety Profile:,Early studies,indicate,minimal risk for genetic mutations and cardiac toxicity, and the form...
Pro Medicus Surges to Record High on $53 Million U.S. Contract Win
February 04, 2025 11:08 AM AEDT| By Team Kalkine MediaHighlights,Pro Medicus shares hit a record high of $281.25, gaining 4% in morning trade.,The company secured a seven-year, $53 million contract with U.S.-based healthcare system BayCare.,Shares have soared nearly 160% over the past year.,Shares of Pr...
Advertise your brand on Kalkine Media